Literature DB >> 26519686

The medical and socioeconomic burden of heart failure: A comparative delineation with cancer.

Dimitrios Farmakis1, Panagiotis Stafylas2, Gregory Giamouzis3, Nikolaos Maniadakis4, John Parissis5.   

Abstract

Cardiovascular disease and cancer represent the two leading causes of death in the Western World. Still, cardiovascular disease causes more deaths and more hospitalizations than cancer. Although mortality rates of both conditions are generally declining, this is not true for heart failure (HF). The prevalence of HF is increasing, although its incidence has been stabilized, mainly because of the population aging. The survival of patients with HF is overall worse than those with cancer. In addition, HF failure is the most common reason for hospitalization in the elderly, while hospitalization for HF is followed by adverse prognosis and represents the main contributor to the huge financial expenditure caused by the syndrome. The outcome of HF patients and thus its medical and socioeconomic burden may be improved by the more efficient in-hospital management of patients, the enhancement of adherence to guideline-recommended therapies, the identification and treatment of comorbid conditions and the introduction of more effective medical therapies.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cancer; Cardiovascular disease; Cost; Epidemiology; Healthcare; Heart failure

Mesh:

Year:  2015        PMID: 26519686     DOI: 10.1016/j.ijcard.2015.10.172

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  15 in total

Review 1.  The Impact of Pazopanib on the Cardiovascular System.

Authors:  Cody N Justice; Mohamed H Derbala; Tesla M Baich; Amber N Kempton; Aaron S Guo; Thai H Ho; Sakima A Smith
Journal:  J Cardiovasc Pharmacol Ther       Date:  2018-04-29       Impact factor: 2.457

2.  Cardiovascular Disease in Hispanics/Latinos in the United States.

Authors:  Pelbreton C Balfour; John M Ruiz; Gregory A Talavera; Matthew A Allison; Carlos J Rodriguez
Journal:  J Lat Psychol       Date:  2016-05

3.  Inhibiting the Pkm2/b-catenin axis drives in vivo replication of adult cardiomyocytes following experimental MI.

Authors:  Ludger Hauck; Keith Dadson; Shelly Chauhan; Daniela Grothe; Filio Billia
Journal:  Cell Death Differ       Date:  2020-12-07       Impact factor: 15.828

4.  Left ventricular remodeling leads to heart failure in mice with cardiac-specific overexpression of VEGF-B167: echocardiography and magnetic resonance imaging study.

Authors:  Line Lottonen-Raikaslehto; Riina Rissanen; Erika Gurzeler; Mari Merentie; Jenni Huusko; Jurgen E Schneider; Timo Liimatainen; Seppo Ylä-Herttuala
Journal:  Physiol Rep       Date:  2017-03

5.  Phase 3 DREAM-HF Trial of Mesenchymal Precursor Cells in Chronic Heart Failure.

Authors:  Kenneth M Borow; Alex Yaroshinsky; Barry Greenberg; Emerson C Perin
Journal:  Circ Res       Date:  2019-07-18       Impact factor: 17.367

6.  Cardiac Index by Transthoracic Echocardiography (CITE) study.

Authors:  Barna Szabó; Eszter Krisztina Marosi; Katarina Vargová; Noémi Nyolczas
Journal:  PLoS One       Date:  2018-12-12       Impact factor: 3.240

Review 7.  The management of atrial fibrillation in heart failure: an expert panel consensus.

Authors:  Dimitrios Farmakis; Christina Chrysohoou; Gregory Giamouzis; George Giannakoulas; Michalis Hamilos; Katerina Naka; Stylianos Tzeis; Sotirios Xydonas; Apostolos Karavidas; John Parissis
Journal:  Heart Fail Rev       Date:  2021-11       Impact factor: 4.214

8.  The Association Between Alcohol Consumption and Left Ventricular Ejection Fraction: An Observational Study on a General Population.

Authors:  Zhao Li; Xiaofan Guo; Yinglong Bai; Guozhe Sun; Yufan Guan; Yingxian Sun; Abraham Maria Roselle
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

9.  Cost of heart failure management in Turkey: results of a Delphi Panel.

Authors:  Dursun Aras; Sinan Aydoğdu; Engin Bozkurt; Yüksel Çavuşoğlu; Mehmet Eren; Çetin Erol; Sadi Güleç; Pınar Kızılırmak; Zeki Öngen; Oktay Özdemir; Mete Saylan; Lale Tokgözoğlu; Ekrem Yeter; Mehmet Birhan Yılmaz
Journal:  Anatol J Cardiol       Date:  2016-08       Impact factor: 1.596

10.  Study protocol, randomized controlled trial: reducing symptom burden in patients with heart failure with preserved ejection fraction using ubiquinol and/or D-ribose.

Authors:  Janet D Pierce; Diane E Mahoney; John B Hiebert; Amanda R Thimmesch; Francisco J Diaz; Carol Smith; Qiuhua Shen; Dinesh Pal Mudaranthakam; Richard L Clancy
Journal:  BMC Cardiovasc Disord       Date:  2018-04-02       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.